Soumon Rudra
Papers
2
Total Citations
7
H-Index
1
About
Soumon Rudra is a clinical researcher whose work focuses on optimizing treatment strategies for oropharyngeal squamous cell carcinoma (OPSCC), particularly in early-stage disease. His major contributions center on comparing real-world outcomes between transoral robotic surgery (TORS) and radiation therapy, using large national cancer databases to provide evidence that complements clinical trial findings. His most cited study, examining ninety-day mortality following TORS or radiation at Commission on Cancer-accredited facilities, analyzed over 4,000 patients from the National Cancer Database (2010-2017) and found a low real-world mortality rate of 0.5%, offering reassurance about the safety of these approaches in appropriately selected patients. This work has garnered 6 citations and helps guide clinical decision-making. In a related study, Rudra identified key factors predictive of primary treatment modality choice in early-stage OPSCC, including tumor stage, nodal status, and facility type, contributing to personalized treatment planning. His research bridges the gap between controlled trial data and everyday clinical practice, providing valuable insights for surgeons and radiation oncologists managing head and neck cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2